Stereotactic radiosurgery for hemangioblastomas of the brain

A. Jawahar, Douglas Kondziolka, Yolanda Isabel Garces, J. C. Flickinger, B. E. Pollock, L. Dade Lunsford

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Objective. To assess the effectiveness of stereotactic radiosurgery in achieving tumor control and improving survival in patients with hemangioblastoma, we evaluated results from patients who were managed at the University of Pittsburgh and the Mayo Clinic. Patients and Methods. Twenty-seven patients with 29 hemangioblastomas had stereotactic radiosurgery over a 10 year interval. The mean patient age was 32 years (range, 14-75 years). The tumor volumes varied from 0.36 to 27 ml (mean, 3.2 ml), and the mean tumor margin dose was 16 Gy (range, 11.7-20). Clinical and neuroimaging follow-up was obtained for all patients between 0.5 and 9 years (mean, 4 years) after radiosurgery. Results. At this assessment, 21 patients (79%) were alive and six (21%) had died. The median survival after radiosurgery was 6.5 years (actuarial 5 year survival = 75.1 ± 11.5%). The median survival from the initial diagnosis was 15 years. Twenty two of 29 evaluable tumors were controlled locally. The two-year actuarial control rate was 84.5 ± 7.1% and at five years, 75.2 ± 8.9%. Multivariate testing of factors affecting good outcome indicated that smaller tumor volume and higher radiosurgical dose (> 18 Gy) were significant. Conclusion. For small to moderate size hemangioblastomas, multiple or recurrent tumors, and for patients who are not surgical candidates, radiosurgery is a safe and effective option to control disease and improve survival.

Original languageEnglish (US)
Pages (from-to)641-645
Number of pages5
JournalActa Neurochirurgica
Volume142
Issue number6
DOIs
StatePublished - 2000

Fingerprint

Hemangioblastoma
Radiosurgery
Brain
Survival
Tumor Burden
Neoplasms
Neuroimaging

Keywords

  • Gamma knife
  • Hemangioblastoma
  • Radiosurgery
  • von Hippel Lindau disease

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Jawahar, A., Kondziolka, D., Garces, Y. I., Flickinger, J. C., Pollock, B. E., & Lunsford, L. D. (2000). Stereotactic radiosurgery for hemangioblastomas of the brain. Acta Neurochirurgica, 142(6), 641-645. https://doi.org/10.1007/s007010070107

Stereotactic radiosurgery for hemangioblastomas of the brain. / Jawahar, A.; Kondziolka, Douglas; Garces, Yolanda Isabel; Flickinger, J. C.; Pollock, B. E.; Lunsford, L. Dade.

In: Acta Neurochirurgica, Vol. 142, No. 6, 2000, p. 641-645.

Research output: Contribution to journalArticle

Jawahar, A, Kondziolka, D, Garces, YI, Flickinger, JC, Pollock, BE & Lunsford, LD 2000, 'Stereotactic radiosurgery for hemangioblastomas of the brain', Acta Neurochirurgica, vol. 142, no. 6, pp. 641-645. https://doi.org/10.1007/s007010070107
Jawahar A, Kondziolka D, Garces YI, Flickinger JC, Pollock BE, Lunsford LD. Stereotactic radiosurgery for hemangioblastomas of the brain. Acta Neurochirurgica. 2000;142(6):641-645. https://doi.org/10.1007/s007010070107
Jawahar, A. ; Kondziolka, Douglas ; Garces, Yolanda Isabel ; Flickinger, J. C. ; Pollock, B. E. ; Lunsford, L. Dade. / Stereotactic radiosurgery for hemangioblastomas of the brain. In: Acta Neurochirurgica. 2000 ; Vol. 142, No. 6. pp. 641-645.
@article{183bc4faacb445ea8d4578fd96e6b637,
title = "Stereotactic radiosurgery for hemangioblastomas of the brain",
abstract = "Objective. To assess the effectiveness of stereotactic radiosurgery in achieving tumor control and improving survival in patients with hemangioblastoma, we evaluated results from patients who were managed at the University of Pittsburgh and the Mayo Clinic. Patients and Methods. Twenty-seven patients with 29 hemangioblastomas had stereotactic radiosurgery over a 10 year interval. The mean patient age was 32 years (range, 14-75 years). The tumor volumes varied from 0.36 to 27 ml (mean, 3.2 ml), and the mean tumor margin dose was 16 Gy (range, 11.7-20). Clinical and neuroimaging follow-up was obtained for all patients between 0.5 and 9 years (mean, 4 years) after radiosurgery. Results. At this assessment, 21 patients (79{\%}) were alive and six (21{\%}) had died. The median survival after radiosurgery was 6.5 years (actuarial 5 year survival = 75.1 ± 11.5{\%}). The median survival from the initial diagnosis was 15 years. Twenty two of 29 evaluable tumors were controlled locally. The two-year actuarial control rate was 84.5 ± 7.1{\%} and at five years, 75.2 ± 8.9{\%}. Multivariate testing of factors affecting good outcome indicated that smaller tumor volume and higher radiosurgical dose (> 18 Gy) were significant. Conclusion. For small to moderate size hemangioblastomas, multiple or recurrent tumors, and for patients who are not surgical candidates, radiosurgery is a safe and effective option to control disease and improve survival.",
keywords = "Gamma knife, Hemangioblastoma, Radiosurgery, von Hippel Lindau disease",
author = "A. Jawahar and Douglas Kondziolka and Garces, {Yolanda Isabel} and Flickinger, {J. C.} and Pollock, {B. E.} and Lunsford, {L. Dade}",
year = "2000",
doi = "10.1007/s007010070107",
language = "English (US)",
volume = "142",
pages = "641--645",
journal = "Acta Neurochirurgica",
issn = "0001-6268",
publisher = "Springer Wien",
number = "6",

}

TY - JOUR

T1 - Stereotactic radiosurgery for hemangioblastomas of the brain

AU - Jawahar, A.

AU - Kondziolka, Douglas

AU - Garces, Yolanda Isabel

AU - Flickinger, J. C.

AU - Pollock, B. E.

AU - Lunsford, L. Dade

PY - 2000

Y1 - 2000

N2 - Objective. To assess the effectiveness of stereotactic radiosurgery in achieving tumor control and improving survival in patients with hemangioblastoma, we evaluated results from patients who were managed at the University of Pittsburgh and the Mayo Clinic. Patients and Methods. Twenty-seven patients with 29 hemangioblastomas had stereotactic radiosurgery over a 10 year interval. The mean patient age was 32 years (range, 14-75 years). The tumor volumes varied from 0.36 to 27 ml (mean, 3.2 ml), and the mean tumor margin dose was 16 Gy (range, 11.7-20). Clinical and neuroimaging follow-up was obtained for all patients between 0.5 and 9 years (mean, 4 years) after radiosurgery. Results. At this assessment, 21 patients (79%) were alive and six (21%) had died. The median survival after radiosurgery was 6.5 years (actuarial 5 year survival = 75.1 ± 11.5%). The median survival from the initial diagnosis was 15 years. Twenty two of 29 evaluable tumors were controlled locally. The two-year actuarial control rate was 84.5 ± 7.1% and at five years, 75.2 ± 8.9%. Multivariate testing of factors affecting good outcome indicated that smaller tumor volume and higher radiosurgical dose (> 18 Gy) were significant. Conclusion. For small to moderate size hemangioblastomas, multiple or recurrent tumors, and for patients who are not surgical candidates, radiosurgery is a safe and effective option to control disease and improve survival.

AB - Objective. To assess the effectiveness of stereotactic radiosurgery in achieving tumor control and improving survival in patients with hemangioblastoma, we evaluated results from patients who were managed at the University of Pittsburgh and the Mayo Clinic. Patients and Methods. Twenty-seven patients with 29 hemangioblastomas had stereotactic radiosurgery over a 10 year interval. The mean patient age was 32 years (range, 14-75 years). The tumor volumes varied from 0.36 to 27 ml (mean, 3.2 ml), and the mean tumor margin dose was 16 Gy (range, 11.7-20). Clinical and neuroimaging follow-up was obtained for all patients between 0.5 and 9 years (mean, 4 years) after radiosurgery. Results. At this assessment, 21 patients (79%) were alive and six (21%) had died. The median survival after radiosurgery was 6.5 years (actuarial 5 year survival = 75.1 ± 11.5%). The median survival from the initial diagnosis was 15 years. Twenty two of 29 evaluable tumors were controlled locally. The two-year actuarial control rate was 84.5 ± 7.1% and at five years, 75.2 ± 8.9%. Multivariate testing of factors affecting good outcome indicated that smaller tumor volume and higher radiosurgical dose (> 18 Gy) were significant. Conclusion. For small to moderate size hemangioblastomas, multiple or recurrent tumors, and for patients who are not surgical candidates, radiosurgery is a safe and effective option to control disease and improve survival.

KW - Gamma knife

KW - Hemangioblastoma

KW - Radiosurgery

KW - von Hippel Lindau disease

UR - http://www.scopus.com/inward/record.url?scp=0034044441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034044441&partnerID=8YFLogxK

U2 - 10.1007/s007010070107

DO - 10.1007/s007010070107

M3 - Article

C2 - 10949438

AN - SCOPUS:0034044441

VL - 142

SP - 641

EP - 645

JO - Acta Neurochirurgica

JF - Acta Neurochirurgica

SN - 0001-6268

IS - 6

ER -